New Posts

Feb 8, 2016

Top 400 Taxpayers See Tax Rates Rise, But There’s More to the Story

As Americans were gathering party supplies to greet the New Year, the Internal Revenue Service released their annual report of cumulative tax data reported on the 400 tax r...

read in full
Feb 4, 2016

Chlorine Bleach Plants Needlessly Endanger 63 Million Americans

Chlorine bleach plants across the U.S. put millions of Americans in danger of a chlorine gas release, a substance so toxic it has been used as a chemical weapon. Greenpeace’s new repo...

read in full
Jan 25, 2016

U.S. Industrial Facilities Reported Fewer Toxic Releases in 2014

The Toxics Release Inventory (TRI) data for 2014 is now available. The good news: total toxic releases by reporting facilities decreased by nearly six percent from 2013 levels. Howe...

read in full
Jan 22, 2016

Methane Causes Climate Change. Here's How the President Plans to Cut Emissions by 40-45 Percent.

  UPDATE (Jan. 22, 2016): Today, the Bureau of Land Management (BLM) released its proposed rule to reduce methane emissions...

read in full
more news

FDA Commissioner Opposes Commonsense Tobacco Bill

FDA commissioner Dr. Andrew von Eschenbach is opposed to bipartisan legislation that would allow FDA to regulate tobacco products. Sensible bills in both the House and the Senate would dramatically improve public health as it relates to tobacco products. The bill would do so by placing the tobacco industry — which currently goes unregulated — under the purview of FDA. In a Mar. 6 interview with the Associated Press, von Eschenbach manipulates the facts in his opposition to the bill. His specious arguments are a poorly veiled attempt to side with the tobacco industry. He also claimed tobacco products are too complex for the FDA to handle. How can an FDA commissioner hold such little regard for his own agency? One of the bills sponsors, Rep. Henry Waxman (D-CA), wrote a letter to von Eschenbach asking him to correct his various misstatements. Your statements suggest a serious misunderstanding of the bill and appear to ignore overwhelming evidence that such regulation is necessary to address the continuing epidemic of tobacco-related death and disease. Waxman then discredits von Eschenbach's argument point by point. Waxman's letter is a pleasure to read (as his Bush administration proddings usually are). Check this one out here.

read in full

Latest Watcher

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Regulatory policy articles this time: Bush Continues Anti-Regulatory Efforts with Industry Nominee to CPSC Scientific Consultant Sparks Controversy over Conflicts of Interest In Congress, No Shortage of Fuel Economy Proposals

read in full

Scientific Consultant Sparks Controversy over Conflicts of Interest

Recent findings indicate a consultant to a federal reproductive health sciences panel also has industry ties, creating a conflict of interest. The controversy raises concerns about scientific integrity in the federal regulatory process, as well as contractor transparency and responsibility.

read in full

Bush Continues Anti-Regulatory Efforts with Industry Nominee to CPSC

In nominating Michael E. Baroody Mar. 1 to be chairman of the Consumer Product Safety Commission (CPSC), President Bush demonstrated yet another example since the 2006 elections of his efforts to slow down or roll back government regulation. CPSC is the independent regulatory agency charged with protecting the public against injury and death from a wide range of consumer products.

read in full

Bush Nominates Manufacturing Ally to CPSC

Thursday, President Bush nominated Michael Baroody to be a commissioner on the Consumer Product Safety Commission (CPSC). Baroody is the current executive vice president of the National Association of Manufacturers, a trade group whose mission includes "shaping a legislative and regulatory environment" on behalf of manufacturers. Baroody's ability to shape America's regulatory environment will take on new meaning if he becomes a CPSC commissioner. The CPSC is the independent agency charged with protecting the public from dangerous products. The commissioners (of which there are only three) must be able to work with manufacturers to assess product safety, but also exert authority when industry cooperation does not go far enough in protecting the public. If you think a commissioner with such obvious strong ties to the industry he must regulate is a bad idea, you are not alone. Public interest groups are already sounding the alarms, and Sen. Barbara Boxer (D-CA) says she will give the nomination "thorough scrutiny," according to the LA Times. As Reg•Watch has blogged in the past, the CPSC has been short a commissioner since July, and its voting quorum recently expired. I find it depressing to have to contemplate which is worse: a commissioner like Michael Baroody, or no commissioner at all.

read in full

Latest Developments on Bush Changes to the Regulatory Process

OMB Watch has created a new web center to be the one-stop source for news and developments on President Bush's recent amendments to Executive Order 12866. The web center will be frequently updated with fresh insights, news from Capitol Hill, and links to media coverage.

read in full

Public Citizen Urges Congress to Make Cars Safer for Kids

Yesterday, Joan Claybrook, president of the public interest group Public Citizen, testified before a Senate subcommittee on vehicle safety for children. Claybrook urged Congress and the National Highway Traffic Safety Administration (NHTSA) to improve vehicle safety in an effort to reduce the number of children killed in vehicle related accidents — currently about five per day. Claybrook also chided the Bush administration for renominating Susan Dudley to be the White House's regulatory czar. As OMB Watch has pointed out numerous times (here, here, and here), Dudley's views are not consistent with those of the public and her installation would likely cause unprecedented rollbacks in health and safety regulations. Read more about Claybrook's testimony here.

read in full

Cuts at FDA Jeopardize Stomachs, Security

Amid high profile food safety crises such as the spinach contamination of 2006 and recent salmonella tainted peanut butter, the FDA has been reducing its commitment to food safety, according to an Associated Press article.
  • There are 12 percent fewer FDA employees in field offices who concentrate on food issues.
  • Safety tests for U.S.-produced food have dropped nearly 75 percent, from 9,748 in 2003 to 2,455 last year, according to the agency's own statistics.
The article also reminds us food safety is a legitimate homeland security concern: After the Sept. 11 attacks, the FDA, at the urging of Congress, increased the number of food inspectors and inspections amid fears that the nation's food system was vulnerable to terrorists. Inspectors and inspections spiked in 2003, but now both have fallen enough to erase the gains. One wonders if the pullout of FDA employees has emboldened the enemy.

read in full

Politics Makes Strange Bedfellows ... Then Enjoys a Smoke

Roll Call (subscription) ran an article this morning discussing the lobbying efforts aimed at the tobacco regulation bills currently in both chambers of Congress. In addition to the tobacco industry, the Petroleum Marketing Association of America and three advertising industry coalitions oppose the bill, according to the article. Why would seemingly disinterested parties oppose a common sense bill to regulate tobacco products? Because gas station owners make big money by selling cigarettes, and advertising companies make big money by promoting them. As if Big Tobacco is not enough of a force in Washington, now it's lining up its friends. Nonetheless, the bill moves forward. One of the Senate sponsors, Ted Kennedy, chairs a committee hearing on the bill today. As the Roll Call article points out, no industry representatives are scheduled to testify. Stay tuned to Reg Watch for more.

read in full

Latest Watcher

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Reg policy articles this time: Congress Holds Hearings on Bush's Changes to Regulatory Process FDA Drug Approval Process under Scrutiny

read in full

Pages

Resources & Research

Living in the Shadow of Danger: Poverty, Race, and Unequal Chemical Facility Hazards

People of color and people living in poverty, especially poor children of color, are significantly more likely...

read in full

A Tale of Two Retirements: One for CEOs and One for the Rest of Us

The 100 largest CEO retirement funds are worth a combined $4.9 billion, equal to the entire retirement account savings of 41 percent of American fam...

read in full
more resources